Targeting Innate Immunity to Combat Cutaneous Stress: The Vitiligo Perspective

Front Immunol. 2021 Apr 14:12:613056. doi: 10.3389/fimmu.2021.613056. eCollection 2021.

Abstract

Multiple factors are involved in the process leading to melanocyte loss in vitiligo including environmental triggers, genetic polymorphisms, metabolic alterations, and autoimmunity. This review aims to highlight current knowledge on how danger signals released by stressed epidermal cells in a predisposed patient can trigger the innate immune system and initiate a cascade of events leading to an autoreactive immune response, ultimately contributing to melanocyte disappearance in vitiligo. We will explore the genetic data available, the specific role of damage-associated-molecular patterns, and pattern-recognition receptors, as well as the cellular players involved in the innate immune response. Finally, the relevance of therapeutic strategies targeting this pathway to improve this inflammatory and autoimmune condition is also discussed.

Keywords: DAMPs; DC; ILC; PAMPs; innate immunity; melanocytes; vitiligo.

Publication types

  • Review

MeSH terms

  • Animals
  • Biomarkers
  • Combined Modality Therapy
  • Disease Management
  • Disease Susceptibility / immunology
  • Genetic Predisposition to Disease
  • Humans
  • Immunity, Innate / drug effects*
  • Lymphocyte Subsets / immunology
  • Lymphocyte Subsets / metabolism
  • Receptors, Pattern Recognition / metabolism
  • Signal Transduction
  • Skin / drug effects*
  • Skin / immunology*
  • Skin / pathology
  • Stress, Physiological / drug effects*
  • Vitiligo / drug therapy
  • Vitiligo / etiology*
  • Vitiligo / metabolism
  • Vitiligo / pathology

Substances

  • Biomarkers
  • Receptors, Pattern Recognition